- In May 2026, GBG announced it is expanding its partnership with Equifax into the US, integrating Equifax Identity and Fraud solutions into its GBG Go platform while Equifax plans to adopt GBG’s data verification capabilities to strengthen real-time address and location checks.
- This deepened data-sharing alliance aims to help global customers better tackle synthetic identity fraud and credit file integrity at a time when the cost of fraud is projected to reach very large loss levels by 2030.
- We’ll now examine how this expanded fraud and identity partnership with GBG might influence Equifax’s investment narrative and long-term positioning.
Uncover the next big thing with 25 elite penny stocks that balance risk and reward.
Equifax Investment Narrative Recap
To own Equifax, you generally need to believe its data, analytics and fraud tools can stay central to lending and identity decisions despite legal, regulatory and competitive pressures. The expanded GBG partnership strengthens Equifax’s fraud and identity offering, but does not materially change the near term focus on executing product adoption and managing ongoing litigation and compliance costs, which remain key catalysts and risks for the equity story right now.
Among recent developments, the class action in Canada over alleged credit file inaccuracies is particularly relevant alongside the GBG news, as it highlights the tension between richer data sharing and the legal exposure that can arise when records are incorrect. For investors, this reinforces that product and partnership wins in identity and fraud need to be weighed against the possibility of elevated litigation expenses and stricter oversight of how Equifax maintains and uses consumer data.
Yet, while partnerships like GBG can support the product story, investors should also be aware of rising legal costs and tightening scrutiny around...
Read the full narrative on Equifax (it's free!)
Equifax's narrative projects $8.3 billion revenue and $1.3 billion earnings by 2029. This requires 9.7% yearly revenue growth and an earnings increase of about $0.6 billion from $698.7 million today.
Uncover how Equifax's forecasts yield a $229.19 fair value, a 40% upside to its current price.
Exploring Other Perspectives
Three Simply Wall St Community fair value estimates for Equifax range from US$223.71 to US$392.83, underlining how far opinions can spread. You should weigh those views against the risk that higher litigation and compliance costs could constrain profitability and affect how the market ultimately prices the business.
Explore 3 other fair value estimates on Equifax - why the stock might be worth over 2x more than the current price!
Reach Your Own Conclusion
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your Equifax research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
- Our free Equifax research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Equifax's overall financial health at a glance.
Curious About Other Options?
Our top stock finds are flying under the radar-for now. Get in early:
- AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
- The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 27 best rare earth metal stocks of the very few that mine this essential strategic resource.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com